Adelphi IN Real World, Value & Outcomes

Over 20 years of real-world evidence generation. Provide real world evidence through Adelphi Real World Disease Specific Programmes™.

We identify and analyse the right data sources to meet your objectives through Generate™ integrated data studies.

Our dedicated value and market access PROVE team partner with our clients to define, demonstrate and communicate differentiated value messages. Providing extensive and in-depth experience in market access, pricing and reimbursement, health economics outcomes and evidence generation, along with supporting innovative communication with our impactful value access and health economic tools e-v@luate™ and PACE™.

We are experts in patient access decision making processes. Bespoke research team provide specialist expertise in design and conduct of non-interventional studies. Our Patient-Centered Outcomes team are specialists in clinical outcome assessment development, evaluation and analysis.

• Real-world evidence captured across 50 distinct disease areas using our validated, citable methodology
• RWE programmes that span geographies – Europe, North America, Asia, LATAM and the Middle East
• Dedicated franchise teams with expert up-to-date disease area knowledge supplemented and kept current through regular attendance at conferences
• In house teams of health economists, statisticians, pricing and market access consultants and branding/insights strategists